Pre , in t ra a n d p o st o p e ra t ive . Vi ta l ly i mp o rta n t i s th e p reo p era ti ve d e ci sio n ma kin g a n d p la n n in g . An exp e r tly p er fo r med o p e ra tio n fo r a w ro n g r ea so n i s s ti ll a b a d o p era t io n . 
Introduction
Breast diseases includes a variety of lesions including inflammatory, neoplastic and hormonal response disorders. The majority of the lesions that occur in the breast are benign. However much concern is given to the malignant lesions of the breast, as breast malignancy is one of the commonest malignancy in women throughout the world. 1 Breast lungs constitutes significant number of cases seen in surgical cut patient departments and frequently the need arises to distinguish between benign and malignant lumps prior to definitive treatment. 2 In recent past FNAC and Tru-cut biopsy has replaced incisional or excisional biopsy in diagnosing a breast lumph, because of its distinct advantages like out patient procedure, cost effectiveness, no need general anaesthesia less pain compared to incisional and excisional biopsy. 2 Sometimes it is difficult to determine whether a suspicious lump in the breast is benign or malignant, simply with clinical examination and FNAC. Hence, combination of various different investigations arise frequently.
FNAC and Tru-cut biopsy are complementary procedures 3, 4 Pinder and Associated (19960) and Masood (1996) 3 have stated there is insufficient evidence to decide if one method is better than another. These authors recommended the use of the appropriate combination of FNAC and/or Tru-cut biopsy as the best approach for he diagnosis of breast lesions at difficult settings.
So, the purpose of this study it to see and evaluate our experience with FNAC and Tru-cut biopsy in a series of patients and compare the results with post operative final diagnosis.
II. Materials And Methods

Method of study:
Prospective study of patients admitted in KSHEMA hospital with lump in the breast.
Setting:
Department of General Surgery, KSHEMA Hospital.
Methodology:
Detailed history was taken from the patients. Thorough General Physical Examination, local examination and systemic examination was carried out in each patient and entered in Performa. All the patients underwent FNAC and Tru-cut Biopsy following informed consent and findings were documented. All the patients were subjected to Surgery and post operativehisto pathological diagnosis was documented and compared to preoperative findings of FNAC and Tru-cut biopsy. 
III. Method Of Dat A Collection
The results of this study were calculated by using the methodology of Galen and Gambino for substantiating the correlation 
IV. Results
Age: Out of 30 women studied ,age incidence was ranged between 23 to 76 years (mean age 43.76 years) The age incidence for the benign breast lesions ranged from 23 to 51 years (mean age 32.37years). The incidence for malignant breast lesion ranged from 34 to 76 years (mean age 50.74Years) 
Size Of Lump
The size of the breast lump ranged from 4X3 cm to 20X10cms. The Benign lesions ranged from 4X3cms to 20X10cms. Malignant lesions were ranged between 5X4cm to 18X12cms. 
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V. Discussion
In present study which was conducted on 30 female patients who presented with clinically palpable breast lump all the patients underwent FNAC and Tru-cut biopsy of the lump followed by surgery in the form of definitive surgical procedures. On basis of FNAC and Tru-cut biopsy a preparative diagnosis was attained which was then finally compared with the post surgery histopathology, to see the accuracy of FNAC and Trucut biopsy and accuracy of both when combined together.
Our study of 30 patients, age incidence was ranged from 23 to 76 years (mean age 43.76 years) and most common age group having breast lump was 31 to 50 years. The incidence for benign breast lesions ranged from 23 to 51 years (mean age 32.37 years). The incidence of malignant lesions ranged from 34 to 76 years (mean age 50.74 years). The most common age group for benign lesions is 21 to 30 years and that of malignant is 41 to 50 years. The study done by A. Khenka et al 37 , the age range was 14 to 61 years with the overall mean age was 37. 5 41 showed similar age patterns. In our study out of 30 patients, 13 patients had lump in right breast, 17 had lump in left breast. Benign lesions were found more common in the left breast, malignant lesions were found more common in the right breast in present study.
A Khemka et al 17 in their study showed left breast involvement in 28 patients while the other 22,right breast involved. No surgical importance can be derived from this observation since patient selection was in no way dictated by involvement of side of breast.
Quadrant of the breast involved in our study, shows that maximum 18(36%) cases out of 30 had lump in the upper outer quadrant of the breast, maximum 8 out of 10 benign cases had lump in lower outer quadrant and maximum of 15 out of 31 malignant cases had lump in upper outer quadrant. O.N. Alema et al 42 , out of total 82 cases 40 cases had lump in upper outer quadrant . O.N. Alema et al 42 , out of total 85 cases 49 cases had lump in upper outer quadrant and out of them 6 cases were malignant in this study malignancy was not found in other quadrants of breast. Hussain43, in his series, had 29 patients with a lump in the upper outer quadrant and 9 had a lump in the upper inner quadrant while 4 patients had a palpable lump in lower quadrants.
Duration of symptoms in our study shows maximum 21((42%) out of all cases presented between 7 to 12 months of duration (mean 11.04 months). The maximum of 13 benign lumps out of 19 presented between 7 to 18 months duration (mean 13 months) and the maximum of 13 malignant lumps out of 13 presented between 7 to 12 months duration (mean 9.7 months). The study by Hussain shows similar kind of findings in his study, duration in his study ranged between 1 month to 2 years with majority of patients having a history of between 6 months to 1 year.
The commonest benign pathology found in our patients was fibroadenoma almost 58% of all benign diagnosis. And the commonest malignant diagnosis was infiltrative ductal carcinoma 412% of all malignant conditions. Tiwari at al in their study of 91 patients also reported fibroadenoma as the predominance benign diagnosis. A Khenika et al 37 in their study, the commonest pathology found was fibroadenoma in 29 patients. Sumaira Zareef et al 44 , and Ashwin 45 also found fibroadenoma as commonest benign lesion.
Fnac & Tru-Cut Biopsy
In our study True positive for FNAC was 45(90%) True negative was 50 (100%) and false positive was zero and false negative was 05 (10%), which lead to the interpretation of sensitivity of 90% for FNAC and specificity of 100% for FNAC. For FNAC in our study positive and negative predictive value was found to be 100% and 90.9% respectively, with an accuracy rate of 95% Our study True positive for True-cut biopsy was 47(94%) True negative was 49(98%) and False positive was 01(02%) and false negative was 03(06%), which lead to the interpretation of sensitivity of 94% for Trucut biopsy and specificity of 98% for Tru cut biopsy. For Tru-cut biopsy in our study positive and negative predictive value was found to be 97.91% and 94.23% respectively, with an accuracy rate of 96%.
In a series of 100 patients, Dennison46, reported the sensitivity of FNAC as 90.4% whereas an absolute value of 90.9% was obtained by the series by Hussain et al. Westend et al 47 ,depicted, a value of 92% for FNAC and Ashwin mentioned sensitivity as 93.10%. In his study Wu et al 49 compared postoperative pathology results and showed a sensitivity of 75% while Tru-cut biopsy showed a sensitivity value of 92%. Randa et al 49 mentioned in their study that the overall sensitivity, specificity and accuracy of FNAC were 56., 809 and 63.8 respectively while those of Tru-cut biopsy (histopathology) were 93.5, 83.5 and 89.7% respectively, almost similar results were found in the study done by saleh FM et al.
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. Conclusion Both FNAC and True cut biopsy are important tool in management of patients with breast lump. When performed by expert hands ,the diagnostic accuracy of both is very high but not 100%.when combined together accuracy is 100%.
Infiltrating ductal carcinoma was predominant malignant breast tumour in our study 47%,majority were found in age group of 41 -50 years. Fibroadenoma was the commonest benign breast tumour in our study 16.7%,majority with age group 21 -30 Years.
Thus we have no hesitation that FNAC and True cut biopsy is a very preliminary diagnostic test in clinically palpable breast lumps, the results show 100% co relation with postoperative histopathology report when combined together .so it can be advised that the patients who have undergone both the above preliminary diagnostic procedures can be directly managed with definitive therapy.
